Keyword: biopharmaceuticals
Markets & Companies
24.11.2017
- Of the remaining post-Brexit 27 member states of the European Union, Ireland looks likely to suffer the most economically, and also possibly politically, as a result of the UK’s...
News
13.06.2017
- The European Commission has approved plans by US healthcare group Johnson & Johnson to acquire Swiss biotech Actelion, thus completing all global regulatory approvals. J&J said it...
News
15.03.2017
- French family-owned group Roquette plans to introduce three new brands to address the growing demand for excipients and raw materials for the biopharmaceutical market. The new...
News
15.03.2016
- US contract drug development and manufacturing services provider Patheon has signed a toll production agreement with leading biotechnology company Amgen. The US firms are based at...
News
15.01.2016
- Swiss fine and specialty chemicals producer Lonza has expanded its mammalian production capacity to meet increased demand for biopharmaceutical development and clinical...
News
12.01.2016
- In a deal worth around $32 billion, Irish drug maker Shire – headquartered in Dublin but managed from Boston, Massachusetts – has agreed a takeover of US biopharmaceutical company...
News
07.01.2016
- Germany’s Merck KGaA and Pfizer of the US are collaborating with US biopharmaceutical company Syndax to evaluate a combination of avelumab and entinostat to treat advanced ovarian...
News
18.12.2015
- US biopharmaceutical group Amgen is buying back from GlaxoSmithKline (GSK) all of its remaining rights to the bone drugs Prolia (denosumab), Xgeva (denosumab) and Vectibix...
